Insider Transactions in Q1 2022 at Quest Diagnostics Inc (DGX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2022
|
Catherine T. Doherty EVP, Regional Businesses |
SELL
Open market or private sale
|
Direct |
7,032
-9.41%
|
$949,320
$135.21 P/Share
|
|
Mar 08
2022
|
Michael E Prevoznik SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
6,228
-13.7%
|
$840,780
$135.21 P/Share
|
|
Mar 07
2022
|
J. E. Davis CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,330
-13.39%
|
$1,342,900
$130.09 P/Share
|
|
Mar 07
2022
|
J. E. Davis CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
19,856
+20.47%
|
$2,581,280
$130.09 P/Share
|
|
Mar 07
2022
|
Catherine T. Doherty EVP, Regional Businesses |
SELL
Payment of exercise price or tax liability
|
Direct |
6,360
-7.84%
|
$826,800
$130.09 P/Share
|
|
Mar 07
2022
|
Catherine T. Doherty EVP, Regional Businesses |
BUY
Grant, award, or other acquisition
|
Direct |
13,392
+14.17%
|
$1,740,960
$130.09 P/Share
|
|
Mar 07
2022
|
Manner Carrie Eglinton SVP, Advanced Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
7,947
-14.11%
|
$1,033,110
$130.09 P/Share
|
|
Mar 07
2022
|
Manner Carrie Eglinton SVP, Advanced Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
16,162
+22.29%
|
$2,101,060
$130.09 P/Share
|
|
Mar 07
2022
|
Mark Guinan Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,475
-9.57%
|
$1,361,750
$130.09 P/Share
|
|
Mar 07
2022
|
Mark Guinan Executive Vice President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
20,780
+15.96%
|
$2,701,400
$130.09 P/Share
|
|
Mar 07
2022
|
Michael E Prevoznik SVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
5,316
-10.47%
|
$691,080
$130.09 P/Share
|
|
Mar 07
2022
|
Michael E Prevoznik SVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
11,544
+18.53%
|
$1,500,720
$130.09 P/Share
|
|
Mar 07
2022
|
Stephen H Rusckowski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
32,570
-8.86%
|
$4,234,100
$130.09 P/Share
|
|
Mar 07
2022
|
Stephen H Rusckowski Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,184
+16.04%
|
$9,123,920
$130.09 P/Share
|
|
Mar 07
2022
|
Michael J Deppe SVP, Corp. Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
914
-1.4%
|
$118,820
$130.09 P/Share
|
|
Mar 07
2022
|
Michael J Deppe SVP, Corp. Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
2,516
+3.62%
|
$327,080
$130.09 P/Share
|
|
Feb 28
2022
|
Michael E Prevoznik SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
661
-1.66%
|
$85,930
$130.0 P/Share
|
|
Feb 24
2022
|
Manner Carrie Eglinton SVP, Advanced Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
11,745
+13.55%
|
-
|
|
Feb 24
2022
|
Michael E Prevoznik SVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,741
+6.43%
|
-
|
|
Feb 24
2022
|
Michael E Prevoznik SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
1,669
-4.3%
|
$210,294
$126.26 P/Share
|
|
Feb 24
2022
|
Mark Guinan Executive Vice President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,251
+2.48%
|
-
|
|
Feb 24
2022
|
Michael J Deppe SVP, Corp. Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
3,681
+5.66%
|
-
|
|
Feb 24
2022
|
J. E. Davis CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
9,787
+14.59%
|
-
|
|
Feb 24
2022
|
Catherine T. Doherty EVP, Regional Businesses |
BUY
Grant, award, or other acquisition
|
Direct |
3,328
+4.68%
|
-
|
|
Feb 24
2022
|
Catherine T. Doherty EVP, Regional Businesses |
SELL
Open market or private sale
|
Direct |
2,750
-4.1%
|
$346,500
$126.26 P/Share
|
|
Feb 24
2022
|
Stephen H Rusckowski Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,510
+7.04%
|
-
|
|
Feb 23
2022
|
Manner Carrie Eglinton SVP, Advanced Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,977
-3.31%
|
$257,010
$130.16 P/Share
|
|
Feb 23
2022
|
J. E. Davis CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,436
-2.47%
|
$316,680
$130.16 P/Share
|
|
Feb 23
2022
|
Catherine T. Doherty EVP, Regional Businesses |
SELL
Payment of exercise price or tax liability
|
Direct |
1,574
-1.15%
|
$204,620
$130.16 P/Share
|
|
Feb 23
2022
|
Mark Guinan Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,367
-1.34%
|
$307,710
$130.16 P/Share
|
|
Feb 23
2022
|
Michael J Deppe SVP, Corp. Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
313
-0.58%
|
$40,690
$130.16 P/Share
|
|
Feb 23
2022
|
Michael E Prevoznik SVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,339
-1.68%
|
$174,070
$130.16 P/Share
|
|
Feb 23
2022
|
Stephen H Rusckowski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,718
-1.72%
|
$1,263,340
$130.16 P/Share
|